These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
702 related articles for article (PubMed ID: 18502299)
1. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Weng J; Li Y; Xu W; Shi L; Zhang Q; Zhu D; Hu Y; Zhou Z; Yan X; Tian H; Ran X; Luo Z; Xian J; Yan L; Li F; Zeng L; Chen Y; Yang L; Yan S; Liu J; Li M; Fu Z; Cheng H Lancet; 2008 May; 371(9626):1753-60. PubMed ID: 18502299 [TBL] [Abstract][Full Text] [Related]
2. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes. Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754 [TBL] [Abstract][Full Text] [Related]
3. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. Weng J J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564 [TBL] [Abstract][Full Text] [Related]
4. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E; Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial. Chon S; Rhee SY; Ahn KJ; Baik SH; Park Y; Nam MS; Lee KW; Yoo SJ; Koh G; Lee DH; Kim YS; Woo JT; Diabetes Obes Metab; 2018 May; 20(5):1121-1130. PubMed ID: 29272062 [TBL] [Abstract][Full Text] [Related]
6. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.]. Li YB; Zeng LY; Shi LX; Zhu DL; Zhou ZG; Yan L; Tian HM; Luo ZJ; Yang LY; Liu J; Weng JP Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):9-13. PubMed ID: 20356473 [TBL] [Abstract][Full Text] [Related]
7. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes. Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547 [TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847 [TBL] [Abstract][Full Text] [Related]
9. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system. Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes. Lin S; Chen M; Chen W; Lin K; Mu P; Zhu B; Xu W; Wang M; Weng J; Zeng L J Diabetes Res; 2018; 2018():2791584. PubMed ID: 30420969 [TBL] [Abstract][Full Text] [Related]
11. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus. Huang Z; Wan X; Liu J; Deng W; Chen A; Liu L; Liu J; Wei G; Li H; Fang D; Li Y Diabetes Technol Ther; 2013 Oct; 15(10):859-69. PubMed ID: 23991629 [TBL] [Abstract][Full Text] [Related]
12. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study. Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958 [TBL] [Abstract][Full Text] [Related]
13. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose. Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571 [TBL] [Abstract][Full Text] [Related]
14. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus. Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335 [TBL] [Abstract][Full Text] [Related]
15. Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients: basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment. Zeng L; Lu H; Deng H; Mu P; Li X; Wang M Diabetes Technol Ther; 2012 Jan; 14(1):35-42. PubMed ID: 21877913 [TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C; BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112 [TBL] [Abstract][Full Text] [Related]
17. Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study. Ke W; Liu L; Liu J; Chen A; Deng W; Zhang P; Cao X; Liao Z; Xiao H; Liu J; Li Y J Diabetes Res; 2016; 2016():6839735. PubMed ID: 26640805 [TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Jeitler K; Horvath K; Berghold A; Gratzer TW; Neeser K; Pieber TR; Siebenhofer A Diabetologia; 2008 Jun; 51(6):941-51. PubMed ID: 18351320 [TBL] [Abstract][Full Text] [Related]
19. Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. Bergenstal RM; Johnson M; Passi R; Bhargava A; Young N; Kruger DF; Bashan E; Bisgaier SG; Isaman DJM; Hodish I Lancet; 2019 Mar; 393(10176):1138-1148. PubMed ID: 30808512 [TBL] [Abstract][Full Text] [Related]
20. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Bretzel RG; Nuber U; Landgraf W; Owens DR; Bradley C; Linn T Lancet; 2008 Mar; 371(9618):1073-84. PubMed ID: 18374840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]